Related Experiment Video
Updated: Jul 7, 2026

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
Published on: October 13, 2015
Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?
1Henry Wellcome Laboratories for Medical Research, Unit of Infection and Immunity, School of Medicine and Biomedical Sciences, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Abstract:
Lipopolysaccharide (LPS) is a major surface component of Chlamydia trachomatis, as with all Gram-negative bacteria. The effect of C. trachomatis LPS on C. trachomatis infectivity of human epithelial cells was investigated. C. trachomatis LPS and C. trachomatis LPS antibody significantly reduced infectivity, mostly in a dose-dependent manner. As the structure of LPS in C. trachomatis is simple and consists only of lipid A and 3-deoxy-D-manno-octulosonic acid (Kdo), we investigated whether lipid A or Kdo was inhibitory to chlamydial infectivity. Polymyxin B, as a lipid A inhibitor, and Kdo considerably reduced C. trachomatis infectivity. With all the LPS inhibitors used, there was greater inhibition against serovar E than serovar LGV. These results suggest a role for LPS in chlamydial infectivity. Elucidation of how LPS acts in infectivity and identification of host-cell receptors would help in understanding pathogenicity.
Related Concept Videos
Formation of Lipopolysaccharides
Bacterial Phylum Chlamydiae
Trichomoniasis
Sexually Transmitted Infections
Streptococcal Pharyngitis
Determinants of Bacterial Pathogenicity and Virulence

